Niedeggen Andreas, Skobel Erik, Haager Philipp, Lepper Wolfgang, Mühler Eberhard, Franke Andreas
Department of Cardiology, University Hospital, Aachen, Germany.
Cardiol Young. 2005 Aug;15(4):385-90. doi: 10.1017/S1047951105000818.
Objective assessment of the cardiopulmonary capacity in patients with complex congenital cardiac disease often remains difficult in clinical practice. The cardiopulmonary exercise test and determination of the levels of brain natriuretic peptide in the plasma are established tests, but expensive. The 6-minute walk test is also validated, but has not often been used in patients with heart failure due to congenital heart disease, nor compared with other tests. We sought to compare its value with the results of cardiopulmonary exercise testing and measuring the levels of brain natriuretic peptide in the plasma.
We carried out a standardized 6-minute walk test in 31 patients with complex congenital cardiac disease on the same day that they underwent cardiopulmonary exercise testing and determination of levels of brain natriuretic peptide in the plasma. Of the patients, 7 had functionally univentricular hearts, 9 had transposition, 9 had tetralogy of Fallot, 3 had common arterial trunk, and 3 had pulmonary atresia with intact interventricular septum. Uptakes of oxygen at peak exercise, and at the anaerobic threshold, were determined using cardiopulmonary exercise testing, and classified as suggested by Weber. The 6-minute walk test was performed according to a standard protocol.
There was a significant correlation between brain natriuretic peptide, oxygen uptakes at peak exercise and 6-minute walk. The correlation between the 6-minute walk test and oxygen uptakes at the anaerobic threshold, however, was not significant.
The 6-minute walk test can be performed easily, is inexpensive, widely available, and correlates well with measurements of brain natriuretic peptide and cardiopulmonary exercise testing, even in patients with corrected or palliated congenital cardiac malformations. A cut-off value of 450 metres in the 6-minute walk test allows a semi-quantitative classification in analogy to the classification suggested by Weber for cardiopulmonary exercise testing, and to a level of brain natriuretic peptide in the plasma of less or more than 100 picograms per millilitre.
在临床实践中,对复杂先天性心脏病患者的心肺功能进行客观评估往往仍很困难。心肺运动试验和血浆脑钠肽水平测定是已确立的检查方法,但费用昂贵。6分钟步行试验也已得到验证,但在先天性心脏病所致心力衰竭患者中并不常用,也未与其他检查进行比较。我们试图将其价值与心肺运动试验结果及血浆脑钠肽水平测定结果进行比较。
我们对31例复杂先天性心脏病患者在进行心肺运动试验和血浆脑钠肽水平测定的同一天进行了标准化的6分钟步行试验。其中,7例患者为功能性单心室,9例为大动脉转位,9例为法洛四联症,3例为共同动脉干,3例为室间隔完整的肺动脉闭锁。使用心肺运动试验测定峰值运动时和无氧阈时的摄氧量,并按照韦伯的建议进行分类。6分钟步行试验按照标准方案进行。
脑钠肽、峰值运动时摄氧量与6分钟步行距离之间存在显著相关性。然而,6分钟步行试验与无氧阈时摄氧量之间的相关性不显著。
6分钟步行试验操作简便、费用低廉、易于开展,并且与脑钠肽测定及心肺运动试验结果具有良好的相关性,即使在先天性心脏畸形已矫正或姑息治疗的患者中也是如此。6分钟步行试验中450米的临界值可进行半定量分类,类似于韦伯对心肺运动试验及血浆脑钠肽水平低于或高于每毫升100皮克所建议的分类。